To investigate the prevalence of different Plasmodium spp. in wild great apes living in their natural habitat (tropical rainforests), we analyzed tissue samples from 16 wild West African chimpanzees that died primarily of anthrax or respiratory disease in Taï National Park, Côte d’Ivoire. A generic real-time PCR that detects all known Plasmodium spp. was used to test all samples for the parasite. Sequence analysis of the CytB gene and small subunit rRNA genes was conducted for real-time PCR–positive samples to determine the strain present; 1,140 bp of the CytB gene and 765 bp of the 18S gene of the Plasmodium genome were amplified by classic PCR. Resulting products were sequenced either directly or after cloning for rRNA gene and when initial sequence information showed the possible presence of 2 different species (Table).

Phylogenetic analyses of sequences obtained confirmed the presence of 5 species: P. reichenowi and P. gaboni, which had been found previously (2,3); but also P. vivax, P. ovale, and P. malariae–like strains (Figure 1, Figure 2). The most prevalent species was P. reichenowi (6/16), which had representatives in subclusters P. gaboni and P. reichenowi. The other species were rare, seen only 1 (P. ovale and P. vivax) or 2 (P. malariae) times. Two chimpanzees showed co-infections with multiple Plasmodium spp. (Figure 1, Figure 2), 1 infected with P. reichenowi and a P. malariae–like strain and the other with P. reichenowi and P. gaboni.

Is the observed high prevalence of Plasmodium spp. typical for wild chimpanzees or related to reduced immune function associated with the severe infection that was the primary cause of death in each case? To investigate this question, we tested DNA extracted from fecal samples of apparently healthy chimpanzees collected over the past 8 years (n = 30) (11) of the same study population by using the generic real-time PCR followed by amplification of the CytB gene. Of these samples, 21 (70%) were positive for Plasmodium spp. by real-time PCR. Because of low copy numbers in feces, phylogentic analyses were limited to 2 samples in which P. reichenowi of the P. gaboni subcluster was confirmed.

To determine if the observed high prevalence of plasmodia was a site- or chimpanzee subspecies–specific phenomenon, we tested 30 randomly selected fecal samples of individually known apparently healthy wild Eastern chimpanzees from the Budongo Forest in Uganda. Overall prevalence of Plasmodium spp. was lower than in West African chimpanzees but still relatively high (40%); P. reichenowi and P. gaboni were identified in 3 samples.

Our results demonstrate that the prevalence of different Plasmodium spp. in wild chimpanzees is similar to that of untreated human populations in sub-Saharan Africa (www.who.int/malaria). Throughout sub-Saharan Africa, P. falciparum is more predominant in humans than are other Plasmodium spp. Considering the lack of clinical signs of malaria in chimpanzees from which fecal samples were collected and those that had died of respiratory disease or anthrax, Plasmodium spp. infections appear to be asymptomatic or at least nonlethal in wild chimpanzees. However, signs of illness are rarely observed in wild primates because infected animals often mask weakness to maintain social position and avoid attack by predators (12). Recently developed technologies for the noninvasive determination of temperature in wild chimpanzees may enable more effective examination of the relationship between the primary clinical feature of malaria (i.e., cyclical fevers) and Plasmodium spp. infection (13).

P. ovale was previously described from captive chimpanzees and P. malariae from captive chimpanzees and captive bonobos have been described (5–8). Our study results demonstrate that P. malariae and P. ovale occur in wild chimpanzees that inhabit pristine contiguous forest with extremely limited exposure to humans, suggesting the natural existence of these parasites in wild great apes.

Because of a Duffy-negative condition in 95%–99% of the human population in western and central continental Africa, transmission of P. vivax does not seem to occur. However, P. vivax infections are common in travelers returning from these areas (11). Even though we cannot totally exclude the possibility of introduction of P. vivax in the chimpanzee population through humans, our discovery of P. vivax in wild chimpanzees living exclusively within their natural habitat suggests that wild African apes may be a natural reservoir.

Our study shows the existence of P. reichenowi and related strains in wild chimpanzees as described for chimpanzees and gorilla by others (2–4,6). Infections with strains of the P. reichenowi group (sometimes referred to as the species P. gaboni, P. billbrayi, and P. billcollinsi) appear to occur widely in wild and captive great apes in Africa with some variation between chimpanzee subspecies from biogeographically distinct sites. The wild chimpanzees examined demonstrated no infections with classic human P. falciparum. This lack of infection is likely caused by low human presence in their habitat and, consequently, few or no infected vectors, low sample size, or a missing receptor in chimpanzees (14). More investigations are needed because recently P. falciparum infections have been described for 2 captive chimpanzees (6). The situation is clearer for captive and wild lowland gorillas (Gorilla gorilla) for which infections and receptors have recently been described (4). Infections have also been documented for captive bonobos (5).

Previous examination of the role of our closest phylogenetic relatives, the great apes, in the evolution and persistence of human plasmodia has been limited by a lack of data from wild ape populations where opportunities for human-mosquito-ape malaria exchange are minimal. Interpretation of patterns of malaria infection in captive ape populations, such as sanctuaries and zoos, must consider the ample opportunities for human-to-ape transmission of such parasites, negating the opportunity to investigate the evolutionary origins and public health–related risks of these parasites. Conversely, our examination of these parasites in wild chimpanzees with no contact to the periphery of the rainforest habitat (Technical Appendix Figure ) demonstrates that these apes are most likely naturally infected with P. ovale, P. vivax, and P. malariae, 3 types of plasmodia rarely observed in humans of the region. Whether wild great apes are the origin or reservoirs of these Plasmodium types requires further investigation. These results may have implications for global efforts to eradicate malaria in humans, including vaccine development based on animal variants of human parasites.